Pharmacological rescue of p53 in cancer therapy: widening the sensitive tumor spectrum by targeting MDMX.
about
Ocotillol Enhanced the Antitumor Activity of Doxorubicin via p53-Dependent ApoptosisStrategy to enhance efficacy of doxorubicin in solid tumor cells by methyl-β-cyclodextrin: Involvement of p53 and Fas receptor ligand complexSuppression of Myc oncogenic activity by nucleostemin haploinsufficiencyTargeting Mdmx to treat breast cancers with wild-type p53.MDM4 is a rational target for treating breast cancers with mutant p53.The mitochondrial cyclophilin D/p53 complexation mediates doxorubicin-induced non-apoptotic death of A549 lung cancer cells.
P2860
Pharmacological rescue of p53 in cancer therapy: widening the sensitive tumor spectrum by targeting MDMX.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Pharmacological rescue of p53 ...... or spectrum by targeting MDMX.
@en
Pharmacological rescue of p53 ...... or spectrum by targeting MDMX.
@nl
type
label
Pharmacological rescue of p53 ...... or spectrum by targeting MDMX.
@en
Pharmacological rescue of p53 ...... or spectrum by targeting MDMX.
@nl
prefLabel
Pharmacological rescue of p53 ...... or spectrum by targeting MDMX.
@en
Pharmacological rescue of p53 ...... or spectrum by targeting MDMX.
@nl
P1433
P1476
Pharmacological rescue of p53 ...... or spectrum by targeting MDMX.
@en
P304
P356
10.1016/J.CCR.2010.10.026
P577
2010-11-01T00:00:00Z